Name | Number of supported studies | Average coverage | |
---|---|---|---|
enterocyte | 6 studies | 30% ± 11% |
Insufficient scRNA-seq data for expression of NAALADL1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 99% | 764.89 | 179 / 180 | 93% | 5.06 | 401 / 430 |
prostate | 100% | 704.18 | 244 / 245 | 91% | 3.07 | 456 / 502 |
lung | 100% | 552.59 | 577 / 578 | 86% | 2.79 | 993 / 1155 |
thymus | 98% | 298.61 | 641 / 653 | 86% | 2.41 | 518 / 605 |
intestine | 100% | 2575.41 | 966 / 966 | 83% | 3.35 | 438 / 527 |
breast | 100% | 588.86 | 459 / 459 | 81% | 2.14 | 908 / 1118 |
stomach | 86% | 306.09 | 309 / 359 | 85% | 3.65 | 244 / 286 |
bladder | 100% | 575.05 | 21 / 21 | 70% | 2.61 | 355 / 504 |
kidney | 99% | 311.61 | 88 / 89 | 68% | 2.17 | 612 / 901 |
uterus | 100% | 1057.27 | 170 / 170 | 66% | 2.26 | 304 / 459 |
skin | 97% | 303.94 | 1751 / 1809 | 68% | 3.70 | 320 / 472 |
esophagus | 97% | 544.24 | 1397 / 1445 | 58% | 1.36 | 107 / 183 |
adrenal gland | 71% | 123.39 | 182 / 258 | 71% | 4.91 | 164 / 230 |
brain | 47% | 75.83 | 1234 / 2642 | 73% | 1.44 | 516 / 705 |
pancreas | 16% | 21.57 | 52 / 328 | 92% | 3.81 | 164 / 178 |
lymph node | 0% | 0 | 0 / 0 | 100% | 8.26 | 29 / 29 |
spleen | 100% | 803.88 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 100% | 584.43 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 735.07 | 1332 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 92% | 290.20 | 852 / 929 | 0% | 0 | 0 / 0 |
heart | 91% | 253.85 | 785 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 82% | 1.96 | 37 / 45 |
eye | 0% | 0 | 0 / 0 | 78% | 4.34 | 62 / 80 |
liver | 20% | 29.85 | 46 / 226 | 56% | 4.86 | 227 / 406 |
muscle | 25% | 34.81 | 199 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006508 | Biological process | proteolysis |
GO_0043171 | Biological process | peptide catabolic process |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0008233 | Molecular function | peptidase activity |
GO_0004180 | Molecular function | carboxypeptidase activity |
GO_0005509 | Molecular function | calcium ion binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0008237 | Molecular function | metallopeptidase activity |
GO_0004177 | Molecular function | aminopeptidase activity |
Gene name | NAALADL1 |
Protein name | N-acetylated alpha-linked acidic dipeptidase like 1 Aminopeptidase NAALADL1 (EC 3.4.11.-) (100 kDa ileum brush border membrane protein) (I100) (Ileal dipeptidylpeptidase) (N-acetylated-alpha-linked acidic dipeptidase-like protein) (NAALADase L) |
Synonyms | NAALADASEL NAALADL |
Description | FUNCTION: Aminopeptidase with broad substrate specificity. Has lower activity with substrates that have Asp or Glu in the P2' position, or Pro in the P3' position. Lacks activity with substrates that have both Pro in the P3' position and Asp or Glu in the P2' position . Lacks carboxypeptidase activity. Lacks dipeptidyl-peptidase IV type activity . . |
Accessions | ENST00000532802.5 ENST00000356632.7 H0YEI8 C9JFW8 ENST00000530995.5 E9PKR0 ENST00000533842.5 ENST00000358658.8 [Q9UQQ1-1] ENST00000533753.5 E9PLR8 E9PJQ1 ENST00000526516.5 Q9UQQ1 ENST00000526799.5 E9PIU1 H0YDS5 ENST00000340252.8 [Q9UQQ1-4] ENST00000532450.5 ENST00000530139.2 E9PKW7 E9PKG8 E9PII9 ENST00000355721.7 [Q9UQQ1-2] E9PRC7 ENST00000533340.5 ENST00000528884.5 |